A novel synthetic bipartite carrier protein for developing glycotope-based vaccines

► A novel carrier protein has been developed for glycotope-based vaccines. ► The immunogen can activate both B cells and antigen presenting cells. ► This study offers a platform for anti-glycotope vaccine development.